Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

May 25, 2018

Half of Five-Year Survivors of Breast Cancer Are Not Receiving Recommended Post-Surgery Mammograms

Author(s):

Brielle Benyon

NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.

While awareness continues to spread about regular mammograms to detect breast cancer, a recent study published in the Journal of the National Comprehensive Cancer Network (NCCN) found that many breast cancer survivors are not getting the proper level of screening after they have surgery for the disease.

NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.

“This lack of imaging follow-up represents a missed opportunity for identifying recurrent or new breast cancers among a high-risk patient subgroup,” Benjamin O. Anderson, M.D., FACS, vice chair of the NCCN Guidelines Panel for Breast Cancer, said in a statement. Anderson is professor of surgery and global health medicine at the University of Washington and Fred Hutchinson Cancer Research Center.

“Of equal importance, this finding illustrates that our health care system can fail to track sizable groups of cancer patients after completion of treatment,” he said. “The NCCN guidelines for survivorship delineate the quality-of-life issues that patients must address, which together with tests like follow-up mammograms should be a coherent and integrated survivorship plan.”

In the retrospective study, more than 27,000 patients were followed for a median 2.9 years after breast cancer surgery. The study excluded those who underwent bilateral mastectomies, since they do not need mammograms. After 65 months, 4,790 patients remained in the study cohort.

One year after cancer surgery, 13 percent of women did not undergo any breast imaging. As time went on, that number continued to increase. Five years after surgery, 19 percent of women went the year without imaging. In total, only 50 percent of the patients who were followed for five or more years had at least one mammogram per year.

The researchers on the study also found that African-American survivors were less likely than Caucasian survivors to get their yearly mammograms. This is particularly a point of interest since black women die of breast cancer at a higher rate than white women, and recurrence is a major driver for this.

According to the American Cancer Society, between the years 2009 and 2013, for every 100,000 people, 29.6 African-Americans died of the disease, compared to an average of 21 people per 100,000 in Caucasians. Limited access by black women to genetic testing could be a factor, according to the NCCN, but further research is needed to better understand why this disparity exists.

“The use of regular mammograms to detect a return of breast cancer before any symptoms appear is associated with better overall survival,” said Kathryn Ruddy, M.D., M.P.H., director of cancer survivorship for the Department of Oncology at the Mayo Clinic Cancer Center, in a release.

Ruddy was the lead author on the study and a member of the NCCN Clinical Practice Guidelines in Oncology Panel for Survivorship.

“Therefore, clinicians need to make sure that their patients are fully aware of the role these annual mammograms play in screening for new breast cancers as well as for local recurrences. Creating and implementing survivorship care plans with clear follow-up instructions may help ensure that more survivors adhere to recommended screening schedules,” she said.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Related Content
Advertisement
Patti McGee is an author, a massage therapist and breast cancer survivor of 20 years. Catch up on all of Patti's blogs here!
August 2nd 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee
After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
August 2nd 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
August 2nd 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis
Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 2nd 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of Woman.
August 2nd 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee
Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.
Gedatolisib combo improved PFS in patients with advanced breast cancer after prior therapies: © stock.adobe.com.
August 2nd 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman
Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.
Related Content
Advertisement
Patti McGee is an author, a massage therapist and breast cancer survivor of 20 years. Catch up on all of Patti's blogs here!
August 2nd 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee
After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
August 2nd 2025

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
August 2nd 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis
Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 2nd 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of Woman.
August 2nd 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee
Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.
Gedatolisib combo improved PFS in patients with advanced breast cancer after prior therapies: © stock.adobe.com.
August 2nd 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman
Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.